Northwest Bioth Cmn (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,382 | 1,932 | 1,683 | 1,005 | 1,291 |
| Gross Profit | 1,382 | 1,932 | 1,683 | 1,005 | 1,291 |
| Operating Expenses | 67,890 | 57,440 | 68,864 | 53,707 | 87,896 |
| Operating Income | -66,508 | -55,508 | -67,181 | -52,702 | -86,605 |
| Interest Expense | 7,767 | 5,241 | 6,068 | 5,011 | 8,544 |
| Other Income | -9,503 | -1,850 | -31,783 | 236,839 | -434,672 |
| Pre-tax Income | -83,778 | -62,599 | -105,032 | 179,126 | -529,821 |
| Net Income Continuous | -83,778 | -62,599 | -105,032 | 179,126 | -529,821 |
| Net Income | $-83,778 | $-62,599 | $-105,032 | $179,126 | $-529,821 |
| EPS Basic Total Ops | -0.07 | -0.06 | -0.10 | 0.21 | -0.73 |
| EPS Basic Continuous Ops | -0.07 | -0.06 | -0.10 | 0.21 | -0.73 |
| EPS Diluted Total Ops | -0.07 | -0.06 | -0.10 | -0.06 | -0.73 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 | -0.10 | 0.18 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.06 | -0.10 | N/A | N/A |
| EBITDA(a) | $-62,288 | $-51,611 | $-63,158 | $-50,077 | $-83,505 |